Dr Emma Salisbury Consultant nephrologist
- Patient age group
- Adults
- Consultant registered on
- 15/07/2004
- Primary medical qualifications
- MBChB (Hons)
- Gender
- Female
- Services
- Hospitals
Background
Dr Emma Salisbury was appointed consultant nephrologist at Imperial College Renal and Transplant Centre, Hammersmith Hospital, London in 2016. She is experienced in all aspects of general nephrology (including young adult care from 16 years of age, diabetic nephropathy, glomerular disease, hypertension and renovascular disease), as well as acute kidney failure, chronic kidney failure and haemodialysis. Her particular interest is renal transplantation and she was awarded a PhD by Imperial College London in 2013 following three years of research in transplant immunology.
Dr Salisbury achieved a BSc in Pathology with First Class Honours from the University of Edinburgh in 2001. She went on to qualify in Medicine in 2004 and her MBChB was awarded with Honours: the highest accolade awarded by the University of Edinburgh Medical School. She achieved membership of the Royal College of Physicians in 2007 and her Speciality Certificate Exam in Nephrology in 2016. She was appointed Fellow of the Royal College of Physicians in 2023. All her nephrology training was completed in London.
Expertise
Acute kidney disease, chronic kidney disease, urine abnormalities, haemodialysis, kidney transplant, young adult care (16yrs+)
Research & publications
Beckwith H, Thomas N, Adwaney A, AppELbe M, Gaffney H, Hill P, Moabi D, Prout V, Salisbury E, Webster P, Tomlinson JAP, Brown EA. Gender Differences in Experiences and Expectations of Hemodialysis in a Frail and Seriously Unwell Patient Population. Kidney Int Rep. 2022 Sep 3;7(11):2421-2430.
Ashby DR, Caplin B, Corbett RW, Asgari E, Kumar N, Sarnowski A, Hull R, Makanjuola D, Cole N, Chen J, Nyberg S, Forbes S, McCafferty K, Zaman F, Cairns H, Sharpe C, Bramham K, Motallebzadeh R, Anwari K, Roper T, Salama AD, Banerjee D; pan-London Covid-19 renal audit groups. Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort study. Nephrol Dial Transplant. 2022 Sep 22;37(10):1944-1950.
Ashby DR, Caplin B, Corbett RW, Asgari E, Kumar N, Sarnowski A, Hull R, Makanjuola D, Cole N, Chen J, Nyberg S, McCafferty K, Zaman F, Cairns H, Sharpe C, Bramham K, Motallebzadeh R, Anwari KJ, Salama AD, Banerjee D; Pan-London COVID-19 Renal Audit Group. Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study. Clin J Am Soc Nephrol. 2022 Jun;17(6):843-850.
Seneschall C, Ferguson C, Gopalan D, Salisbury E. Correction to: Long term central venous catheters for haemodialysis causing an extra-cardiac right-to-left shunt. J Nephrol. 2022 Jun;35(5):1549.
Seneschall C, Ferguson C, Gopalan D, Salisbury E. Long term central venous catheters for haemodialysis causing an extra-cardiac right-to-left shunt. J Nephrol. 2022 Jun;35(5):1521-1524.
Topp S, Salisbury E. Lithium use in a patient on haemodialysis with bipolar affective disorder and lithium-induced nephropathy. BMJ Case Rep. 2021 Jul 30;14(7):e242841.
Beckwith HKS, Adwaney A, Appelbe M, Gaffney HT, Hill P, Moabi D, Prout VL, Salisbury E, Webster P, Tomlinson JAP, Brown EA. Perceptions of Illness Severity, Treatment Goals, and Life Expectancy: The ePISTLE Study. Kidney Int Rep. 2021 Mar 3;6(6):1558-1566.
Clarke C, Lucisano G, Prendecki M, Gleeson S, Martin P, Ali M, McAdoo SP, Lightstone L, Ashby D, Charif R, Griffith M, McLean A, Dor F, Willicombe M; ICHNT Renal COVID Group. Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era. Kidney Int Rep. 2021 Jan;6(1):46-55.
Kousios A, Storey R, Troy-Barnes E, Hamady M, Salisbury E, Duncan N, Charif R, Tam FWK, Cook HT, Crane J, Chaidos A, Roufosse C, Flora R. Plasmacytoma-Like Posttransplant Lymphoproliferative Disease in a Disused Arteriovenous Fistula: The Importance of Histopathology. Kidney Int Rep. 2019 Feb 13;4(5):749-755.
Salisbury EM, Game DS, Lechler RI. Transplantation tolerance. Pediatr Nephrol. 2014 Dec;29(12):2263-72
Salisbury EM, Wang L, Choi O, Rutschmann S, Ashton-Rickardt PG. N-Ethyl-N-nitrosourea mutagenesis in the mouse provides strong genetic and in vivo evidence for the role of the Caspase Recruitment Domain (CARD) of CARD-MAGUK1 in T regulatory cell development. Immunology. 2014 Mar;141(3):446-56.
McAdoo SP, Brown EA, Chesser AM, Farrington K, Salisbury EM; pan-Thames renal audit group. Measuring the quality of end of life management in patients with advanced kidney disease: results from the pan-Thames renal audit group. Nephrol Dial Transplant. 2012 Apr;27(4):1548-54.
Salisbury E, Frankel A. Just how prepared can we expect new medical graduates to be? Postgrad Med J. 2012 Jul;88(1041):363-4. doi: 10.1136/postgradmedj-2011-130709.
Salisbury EM, Game DS, Al-Shakarchi I, Chan M, Fishman L, Tookman L, Brown EA. Changing practice to improve pain control for renal patients. Postgrad Med J. 2009 Jan;85(999):30-3.
Little MA, Hassan B, Jacques S, Game D, Salisbury E, Courtney AE, Brown C, Salama AD, Harper L. Renal transplantation in systemic vasculitis: when is it safe? Nephrol Dial Transplant. 2009 Oct;24(10):3219-25.
Salisbury EM, Ikin N, Bansi DS. Acute gastrointestinal haemorrhage: a rare presentation of aortic dissection. Br J Hosp Med (Lond). 2008 Jun;69(6):355.